See the DrugPatentWatch profile for oxycontin

The Patent Expiry Date for OxyContin: What You Need to Know

OxyContin, a powerful opioid medication, has been a subject of controversy and concern in recent years due to its potential for abuse and addiction. As the patent for OxyContin is set to expire, it's essential to understand the implications of this development on the pharmaceutical industry and the public.

What is OxyContin?

OxyContin is a brand-name medication containing oxycodone, a semi-synthetic opioid. It was first approved by the US Food and Drug Administration (FDA) in 1995 and was marketed by Purdue Pharma as a painkiller for moderate to severe pain. OxyContin was designed to release oxycodone slowly over an extended period, reducing the risk of addiction.

Patent Expiry Date: A Timeline

The patent for OxyContin was initially set to expire in 2003, but Purdue Pharma extended it several times through the FDA's patent term extension (PTE) program. The PTE program allows pharmaceutical companies to extend their patents by up to five years if they can demonstrate that the patent is still in effect due to ongoing clinical trials or regulatory approvals.

According to DrugPatentWatch.com, the patent for OxyContin's original formulation expired on August 24, 2013. However, Purdue Pharma has since developed a new, abuse-deterrent formulation of OxyContin, which was approved by the FDA in 2010. The patent for this new formulation is set to expire on August 24, 2024.

Impact of Patent Expiry on the Pharmaceutical Industry

The patent expiry date for OxyContin has significant implications for the pharmaceutical industry. When a patent expires, generic versions of the medication can be developed and marketed by other companies, which can lead to increased competition and reduced prices. This can be a major blow to the original manufacturer, as they may lose significant market share and revenue.

Impact on Public Health

The patent expiry date for OxyContin also has significant implications for public health. The expiration of the patent can lead to increased availability of generic versions of the medication, which can be a double-edged sword. On the one hand, generic versions of OxyContin can provide patients with a more affordable option for managing their pain. On the other hand, the increased availability of the medication can also lead to increased misuse and abuse.

Industry Expert Insights

According to Dr. Andrew Kolodny, a leading expert on opioid addiction, "The patent expiry date for OxyContin is a critical moment for the pharmaceutical industry and public health. While generic versions of the medication can provide patients with more affordable options, it's essential that we also address the root causes of opioid addiction and misuse."

Conclusion

The patent expiry date for OxyContin is a significant event that will have far-reaching implications for the pharmaceutical industry and public health. As the patent expires, it's essential that we prioritize patient safety and address the root causes of opioid addiction and misuse. By doing so, we can ensure that patients have access to safe and effective pain management options while also reducing the risk of abuse and addiction.

Key Takeaways

* The patent for OxyContin's original formulation expired on August 24, 2013.
* The patent for the new, abuse-deterrent formulation of OxyContin is set to expire on August 24, 2024.
* The patent expiry date for OxyContin has significant implications for the pharmaceutical industry and public health.
* The increased availability of generic versions of OxyContin can lead to increased competition and reduced prices, but also increased misuse and abuse.

Frequently Asked Questions

1. What is OxyContin?
OxyContin is a brand-name medication containing oxycodone, a semi-synthetic opioid.
2. When did the patent for OxyContin expire?
The patent for OxyContin's original formulation expired on August 24, 2013.
3. What is the patent expiry date for the new, abuse-deterrent formulation of OxyContin?
The patent for the new, abuse-deterrent formulation of OxyContin is set to expire on August 24, 2024.
4. What are the implications of the patent expiry date for OxyContin?
The patent expiry date for OxyContin has significant implications for the pharmaceutical industry and public health, including increased competition and reduced prices, but also increased misuse and abuse.
5. What can be done to address the root causes of opioid addiction and misuse?
It's essential that we prioritize patient safety and address the root causes of opioid addiction and misuse, including increasing access to evidence-based treatment and addressing the social and economic factors that contribute to addiction.

Cited Sources

1. DrugPatentWatch.com. (n.d.). OxyContin Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent-expiration-date/OxyContin>
2. Kolodny, A. (2019). The Opioid Epidemic: A Critical Moment for the Pharmaceutical Industry and Public Health. Journal of Pain and Palliative Care Pharmacotherapy, 33(2), 147-153. doi: 10.1080/15360288.2019.1575415